CORT   $49.83  -3.60% Market Closed After Close 49.85 0.04%

Corcept Therapeutics Inc
Total Cash 380.34M
totalCashPerShare 3.63
EBITDA 144.09M
Total Debt 6.79M
quickRatio 3.509
currentRatio 3.7
Total Revenue 628.56M
debtToEquity 1.063
Revenue/Share 6.107
ROA 0.13002
ROE 0.25773
grossProfits
freeCashflow 140.11M
operatingCashflow 144.65M
earningsGrowth 0.46
revenueGrowth 0.477
grossMargins 0.98440003
ebitdaMargins 0.22923
operatingMargins 0.25527
profitMargins 0.22563
enterpriseValue 5.31B
forwardPE 30.988571
floatShares 85.66M
sharesOutstanding 104.78M
sharesShort 20.68M
sharesShortPriorMonth 21.71M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.87%
Short Ratio help_outline 20.64%
shortPercentOfFloat 0.28%
impliedSharesOutstanding
bookValue 6.101
Price To Book help_outline 8.89
earningsQuarterlyGrowth 0.51
netIncomeToCommon 140.49M
trailingEps 1.31%
forwardEps 1.75%
enterpriseToEbitda 36.84
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.38 4Q 2024
institutionsCount 398
lastUpdated Nov. 7, 2024, 9:23 a.m.